Home
Conditions
Lymphoproliferative Disorders

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,043 public trials 2,030 recruiting studies

Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Completed

Antithymocyte Globulin in Treating Patients Undergoing Stem Cell Transplant for Multiple Myeloma

NCT00378768

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: Fred Hutchinson Cancer Research Center Seattle, Washington, United States

View Trial Details

Completed

Peripheral Stem Cell Transplantation in Treating Patients With Relapsed Low- or Intermediate-Grade Non-Hodgkin's Lymphoma

NCT00006241

Conditions: Chronic Disease, Disease Attributes, Hematologic Diseases, +20 more
Locations: Fred Hutchinson Cancer Research Center Seattle, Washington, United States

View Trial Details

Completed

Bone Marrow Transplantation in Treating Patients With Hematologic Cancer

NCT00005854

Conditions: Blast Crisis, Blood Protein Disorders, Bone Marrow Diseases, +52 more
Locations: Johns Hopkins Oncology Center Baltimore, Maryland, United States

University of Massachusetts Memorial Medical Center Worcester, Massachusetts, United States

University of South Carolina School of Medicine Columbia, South Carolina, United States

Fred Hutchinson Cancer Research Center Seattle, Washington, United States

View Trial Details

Completed

Graft-Versus-Host Disease Prevention in Treating Patients Who Are Undergoing Bone Marrow Transplantation

NCT00002456

Conditions: Chronic Disease, Disease Attributes, Graft Versus Host Disease, +20 more
Locations: Fred Hutchinson Cancer Research Center Seattle, Washington, United States

View Trial Details

Completed

Lymphocyte Infusion in Treating Patients With Relapsed Cancer After Bone Marrow or Peripheral Stem Cell Transplantation

NCT00003887

Conditions: Adnexal Diseases, Blast Crisis, Blood Protein Disorders, +123 more
Locations: Fred Hutchinson Cancer Research Center Seattle, Washington, United States

View Trial Details

Completed

Chemotherapy Plus Radiation Therapy and Biological Therapy in Treating Patients With Hematologic Cancer

NCT00002553

Conditions: Blast Crisis, Blood Protein Disorders, Bone Marrow Diseases, +53 more
Locations: Fred Hutchinson Cancer Research Center Seattle, Washington, United States

View Trial Details

Completed

The Impact of Rituximab in Patients With Primary Breast Diffuse Large B Cell Lymphoma (DLBCL)

NCT01266668

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations: Chonbuk National University Hospital Jeonju, South Korea

View Trial Details

Completed

Monoclonal Antibody Therapy in Treating Patients With Lymphoma or Leukemia

NCT00003874

Conditions: Blood Protein Disorders, Burkitt Lymphoma, Cardiovascular Diseases, +40 more
Locations: Fred Hutchinson Cancer Research Center Seattle, Washington, United States

View Trial Details

Completed

Zevalin Post-marketing Surveillance for Adequateness of Image Interpretation Criteria in Japan

NCT01479387

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations: Many Locations, Japan

View Trial Details

Completed

Curcumin (Diferuloylmethane Derivative) With or Without Bioperine in Patients With Multiple Myeloma

NCT00113841

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: U.T.M.D. Anderson Cancer Center Houston, Texas, United States

View Trial Details

Lymphoproliferative Disorders

Lymphoproliferative Disorders trial results

Related conditions